CUSIP: 29668H104
Q1 2018 13F Holders as of 31 Mar 2018
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
76,181,322
-
Share change
-
+48,335,871
-
Total reported value
-
$10,390,122
-
Price per share
-
$0.19
-
Number of holders
-
9
-
Value change
-
+$9,214,867
-
Number of buys
-
5
-
Number of sells
-
2
Quarterly Holders Quick Answers
What is CUSIP 29668H104?
CUSIP 29668H104 identifies 29668H104 - ESSA PHARMA INC - COM in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
-
Newer quarter:
Q2 2018
-
Previous quarter:
Q4 2017
Recent filing periods for CUSIP 29668H104:
Institutional Holders of ESSA PHARMA INC - COM as of Q1 2018
As of 31 Mar 2018,
ESSA PHARMA INC - COM was held by
9 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
76,181,322 shares.
The largest 9 holders included
Clarus Ventures, LLC, Omega Fund Management, LLC, BVF INC/IL, EVENTIDE ASSET MANAGEMENT, LLC, CVI Holdings, LLC, CITADEL ADVISORS LLC, ROYAL BANK OF CANADA, UBS Group AG, and SUSQUEHANNA INTERNATIONAL GROUP, LLP.
This page lists
9
institutional shareholders reporting positions in this security
for the Q1 2018 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.